The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Tedder, T. F.
Right arrow Articles by Cooper, M. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Tedder, T. F.
Right arrow Articles by Cooper, M. D.

The Journal of Immunology, Vol 130, Issue 4 1668-1673, Copyright © 1983 by American Association of Immunologists


ARTICLES

Expression of C3b receptors on human be cells and myelomonocytic cells but not natural killer cells

TF Tedder, DT Fearon, GL Gartland and MD Cooper

We have examined natural killer (NK) cells, B cells and myelomonocytic cells at different stages of differentiation for the expression of surface C3b receptors (C3bR). Receptor presence was detected using affinity-purified F(ab')2 anti-C3bR antibodies in indirect immunofluorescence assays. NK cells, identified in fetal and adult tissues by the monoclonal antibody HNK-1, were C3bR- except for infrequent C3bR+ HNK-1+ cells in some blood samples. NK cells were not induced to express C3bR by exposure to interferon, target cells, or phorbol myristate acetate. B cells gradually acquired the ability to express C3bR with maturity: 15% of large pre-B cells were C3bR+, 35 to 48% of small pre-B, 60 to 80% of immature B, and 99% of mature B cells. Mature plasma cells were rarely C3bR+. Myelomonocytic cells acquire C3bR relatively late during their development, with neutrophils beginning to express C3bR during the band stage of differentiation. All adult blood myelomonocytic lineage cells, identified by the monoclonal antibody MMA and by morphology, were C3bR+.


This article has been cited by other articles:


Home page
Int ImmunolHome page
J. Schwab and H. Illges
Regulation of CD21 expression by DNA methylation and histone deacetylation
Int. Immunol., May 1, 2001; 13(5): 705 - 710.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. Krych-Goldberg, R. E. Hauhart, V. B. Subramanian, B. M. Yurcisin II, D. L. Crimmins, D. E. Hourcade, and J. P. Atkinson
Decay Accelerating Activity of Complement Receptor Type 1 (CD35). TWO ACTIVE SITES ARE REQUIRED FOR DISSOCIATING C5 CONVERTASES
J. Biol. Chem., October 29, 1999; 274(44): 31160 - 31168.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
N. Borregaard and J. B. Cowland
Granules of the Human Neutrophilic Polymorphonuclear Leukocyte
Blood, May 15, 1997; 89(10): 3503 - 3521.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 1983 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 1983 by The American Association of Immunologists, Inc. All rights reserved.